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INTRODUCTION: Medication-related osteonecrosis of the jaw (MRONJ) is a growing problem within the
ﬁeld of oral and maxillofacial surgery. It is deﬁned as the presence of exposed necrotic alveolar bone
that does not resolve over a period of 8 weeks in a patient taking bisphosphonates, who has not had
radiotherapy to the jaw [1]. Since the ﬁrst report in 2003 that highlighted the potential harm caused by
MRONJ, many more patients have been diagnosed with the condition [2]. The growth in recent years is
likely due to the more potent drugs delivered intravenously however there is some evidence that oral
bisphosphonates given over longer periods of time can have similar effects. Bone exposure may occur
spontaneously or most commonly occurs following an invasive dental procedure, as shown in the case
below [3].
PRESENTATION OF CASE: This case report demonstrates the unpredictable nature of symptoms associated
with medication related osteonecrosis and its management within the hospital environment.
DISCUSSION: This case demonstrastes the unpredictable nature of MRONJ and how the disease can
progress to cause signiﬁcantmorbidity. In this case extensive surgerywas required to remove thenecrotic
fragments of bone with no guarnatee that the necrosis will stop spreading.
CONCLUSION: It seems amatter of great importance that the lasting effects ofMRONJ are known to general
dental and medical practitioners alike. Nationally recognised evidence based guidelines are lacking and
uniformity in the management of MRONJ is required amongst the speciality.
© 2015 The Authors. Published by Elsevier Ltd. on behalf of Surgical Associates Ltd. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Case report
A 77-year old femalewas referred to our clinic with a prolonged
period of delayed healing following the uneventful extraction of
the lower right second molar tooth in May 2007. At this point the
patient had been taking alendronic acid 70mgorally once perweek
for seven years. The patient had a history of osteoporosis and total
hip replacement. Clinical examination revealedonlymild erythema
overlying the socket,withnoevidenceof anyosteonecrotic process,
either clinically of radiographically. The patient was reviewed and
later discharged.
The patient attended the following year in November 2008with
right sided facial pain following recent curettage of the affected
socket by her dentist. The patient was discharged following an
extended course of penicillin V and metronidazole accompanied
with chlorhexidine mouthwashes.
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Over three years later in June 2012 the patient re-attended
with a repeat occurrence of her symptoms. Clinically there was
no evidence of infection or discharge but radiographically there
remained a clearly demarcated radiolucency over the right poste-
rior mandible (Fig. 1).
The patient underwent further curettage, this time under gen-
eral anaesthetic. The histopathology ﬁndings conﬁrmed bone
necrosis consistent with MRONJ, and ruled out dysplasia or malig-
nancy. The patient was discharged following resolution of her
symptoms. The patient’s most recent attendance was in October
2013 where she attended with increasing trismus and some
swelling over the right posterior mandible. Clinically there was
pus draining intraorally from the site. Radiographic examination
revealed a much more extensive area of necrosis at the right body
and ramus of the mandible spreading to involve the coronoid pro-
cess and the appearance of a pathological fracture (Fig. 2).
A CT image was taken to assess the extent of the necrosis. The
CT images and 3D reconstruction are shown below (Figs. 3–5).
Arrangements were made to review her current alendronic acid
therapy.
http://dx.doi.org/10.1016/j.ijscr.2015.02.049
2210-2612/© 2015 The Authors. Published by Elsevier Ltd. on behalf of Surgical Associates Ltd. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).
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Fig. 1. Panoramic radiograph taken 6.6.12.
Fig. 2. Panoramic radiograph taken 27.9.13.
Fig. 3. CT coronal section showing pathological fracture of the right coronoid pro-
cess.
Exploration of the right side of the mandible with removal of
the fractured coronoid process and debridement of necrotic bone
was carried out at The Royal Surrey County Hospital in December
2013. Intraoperative examination revealed pus draining from the
right posterior mandible (Fig. 6).
An incision was made to explore the body, ascending ramus,
and coronoid process of the mandible. The inferior alveolar and
lingual nerves were protected and the coronoid process located.
The coronoid process was gripped ﬁrmly to prevent the temporalis
pulling the fragment superiorly, and gently removed (Fig. 7).
Once the coronoid processwas removed, gentle curettage of the
necrotic bone was carried out using a slow hand piece and saline
irrigation. Necrotic bonewas removed leaving amargin of bleeding
Fig. 4. 3D reconstruction of the CT image showing pathological fracture of the right
coronoid process and the extent of bony necrosis.
Fig. 5. 3D reconstruction of the CT image showing pathological fracture of the right
coronoid process and the extent of bony necrosis.
bone with normal appearance thus indicating sufﬁcient metabolic
potential for healing to take place (Fig. 8) [3–6]. The removed frag-
ment is shown in Fig. 9.
The sitewas thoroughly irrigatedwith chlorhexidine and closed
primarily. The patient was admitted for two nights following the
procedurewhere she received intravenousmetronidazole, andwas
discharged with oral antibiotics and chlorhexidine mouthwashes
four times per day for two weeks.
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Fig. 6. Pus draining from the non-healing mucosa overlying the ascending ramus.
Fig. 7. The coronoid process was gripped with forceps and gently removed.
2. Discussion
This case demonstrates the unpredictable nature of MRONJ and
how the disease can progress to cause signiﬁcant morbidity. In
this case extensive surgery was required to remove the necrotic
fragments of bone with no guarantee that the necrosis will stop
spreading.
Fig. 8. Necrotic bone carefully removed until healthy bone seen.
Fig. 9. Shows the fractured coronoid process and shape conforming to that on the
panoramic radiograph.
At present, the incidence ofMRONJ in patients taking alendronic
acid for osteoporosis is 1:1000–1:1,700 however, this incidence
increases with the duration of treatment [7–9].
Our case illustrates the extent of the damage that can be
caused when straightforward dental procedures are carried out
in low risk patients taking oral bisphosphonates. It is impor-
tant to realise that osteonecrosis may remain asymptomatic for
long periods in the absence of infection [10]. It seems a mat-
ter of great importance that national evidence based guidelines
are published on the dental treatment of patients taking bispho-
sphonates, and that further information regarding the possible
consequences of bisphosphonate use is given to general medical
practitioners.
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